Skip to main content
logo
Nascent Biotech, Inc. (NBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0006
0.00 (0.00%)
Jul 28, 2026, 4:00 PM EST

Nascent Biotech Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Revenue
---10.75-
Revenue Growth
---33.33%--
Gross Profit
-0.3-0.32-10.75-
Operating Income
-2.09-2.23-2.16-0.46-1.4-3.45
Net Income
-1.92-2.09-2.8-0.47-0.96-4
Earnings Per Share
-0.01-0.01-0.02-0.00-0.01-0.12
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Cash & Investments
0.050.370.170.0900
Total Debt
0.060.120.39-0.160.14
Net Cash (Debt)
-0.010.25-0.220.09-0.16-0.14
Net Cash Growth
------
Net Cash Per Share
-0.000.00-0.000.00-0.00-0.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Operating Cash Flow
-1.35-1.19-1.790.41-0.99-0.55
Free Cash Flow
-1.35-1.19-1.790.41-0.99-0.55
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Gross Margin
---100.00%100.00%-
Operating Margin
----45.70%-186.72%-
Pretax Margin
----47.04%-127.84%-
Profit Margin
----47.04%-127.84%-

Valuation
Chart
Fiscal YearCurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJul '26 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
PS Ratio
---6.318.45-